Phygen, LLC has received a patent Notice of Issuance for its interspinous La Costa SnaplokISP as an additional device for use in the treatment of spinal disease and conditions.

The device features a “no screws” stackable design initially announced by Phygen in 2011.

Company executives indicated an interbody system, a posterior cervical pedicle screw and rod fixation system featuring a patent-pending anti-backout screw design, and several other products are in early development.

“We are in the process of completing our filings with the FDA in order to re-commence clinical use of our products,” Tom Gardner, Phygen’s CEO, said in a statement.

The company is focused on the development of devices used in the stabilization and repair of spinal disease and trauma.